These somatotroph biology studies have established Ipamorelin as the definitive selective GH secretagogue for studying pituitary somatotroph biology in pharmacologically clean experimental conditions
A few key take-home points: The weight loss data remain remarkably strong, with semaglutide and tirzepatide showing major reductions in body weight in landmark obesity trials
The commenter stated that the technical advisory panel should make recommendations on the practice expense weights and, if there are significant differences in the purchased service component cost shares, the panel should review and make recommendations regarding the labor-related share
Eli Lilly GLP-1 pill shows promising weight loss in type 2 diabetes trial Eli Lilly says its experimental GLP-1 pill helped overweight adults with Type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in patients without diabetes sent company shares tumbling
The interesting science isnt going anywhere
Questions remaining include optimal human dosing, long-term safety, effects across different populations, interactions with diet and exercise, and whether benefits extend beyond weight loss to improvements in cardiometabolic disease outcomes